Project Grant K08DK147727
- Federal Project Grant Award Summary Oregon Health & Science University received a $1.42 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through June 30, 2030. The award supports basic biomedical research characterizing cellular heterogeneity and defining cell states in specific kidney tubule segments—the thick...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $164,745 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2031. The award funds research to investigate the mechanisms of maternal renal and gestational dysfunction following recovered acute kidney injury (AKI). The research...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pittsburgh a Project Grant totaling $148,986.00 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective August 1, 2025, through July 31, 2030. This five-year research initiative investigates the role of BK gamma (BKγ) auxiliary subunits in regulating potassium secretion within the renal distal nephron, with particular...
- Federal Project Grant Award Summary Oregon Health & Science University received a $1,992,234 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through April 30, 2030. This award funds research on allogeneic hepatocyte transplantation designed to overcome critical barriers to therapeutic liver cell therapy by developing genetically...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $429,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. The award funds research into the structure and function of ATP-sensitive potassium (KATP) channels, which regulate cellular energetics and membrane excitability across multiple physiological systems....
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $166,740 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025, through July 31, 2030. This award funds basic biomedical research aimed at elucidating the mechanisms by which urinary phosphate contributes to chronic kidney...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $234,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 15, 2025, with completion targeted for August 31, 2027. The award funds basic biomedical research aimed at deciphering the molecular mechanisms underlying necrotizing enterocolitis (NEC), a...
- Project Grant Summary Wayne State University received a $115,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 12, 2025, through April 30, 2027. The research project investigates high salt-dependent regulation of the sodium/potassium/2 chloride co-transporter (NKCC2) ubiquitination by E3-ubiquitin ligases in the thick ascending...
- Federal Grant Award Summary The University of South Florida received a $247,697 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 1, 2025, through March 31, 2030. This award funds investigator-initiated biomedical research examining the role of the ANO4 calcium-activated chloride channel in the area postrema (AP) brain region and its...
- Federal Grant Award Summary The University of Oregon received a $2,574,504 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 10, 2025, with completion targeted for August 31, 2027. This research initiative will investigate the mechanism and therapeutic potential of BEFA (Beta-Cell Expansion Factor A), a secreted bacterial protein produced...
Oregon Health & Science University (OHSU) received a $167,400 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through January 31, 2031. This K08 Career Development Award funds mentored research investigating the role of the inwardly rectifying potassium channel KIR4.1 in potassium sensing and signaling within the thick ascending limb (TAL) of the nephron. The research integrates TAL-specific KIR4.1 knockout models with advanced imaging, metabolic phenotyping, tubule perfusion, and single-nucleus RNA sequencing to elucidate how KIR4.1 regulates sodium and potassium handling and drives structural and transcriptional remodeling in response to dietary potassium stress. The deliverables include two primary research objectives: (1) determining how KIR4.1 enables basolateral potassium sensing and regulates TAL transport function, and (2) characterizing structural and transcriptional remodeling of KIR4.1-expressing TAL cells in response to extreme dietary potassium conditions. The award supports structured mentored training in electrophysiology, high-resolution imaging, and transcriptomic analysis, positioning the candidate to establish an independent research program focused on renal epithelial transport in genetic and acquired tubulopathies. The research aims to identify new therapeutic targets for hypokalemic disorders and diuretic resistance by closing knowledge gaps in segment-specific potassium sensing mechanisms.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $167.4k | 4/14/26 |